Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy

Bibliographic Details
Main Authors: Gabrielle Benesh, BS, Tyler M. Andriano, BS, Steven R. Cohen, MD, MPH
Format: Article
Language:English
Published: Elsevier 2021-10-01
Series:JAAD Case Reports
Subjects:
anti-CD20
autoimmune blistering disorder
monoclonal antibody
ocrelizumab
pemphigus vulgaris
rituximab
Online Access:http://www.sciencedirect.com/science/article/pii/S2352512621005506

Internet

http://www.sciencedirect.com/science/article/pii/S2352512621005506

Similar Items